AstraZeneca creates biotech spin-off, $250m in bank
February 28, 2018Research and Development, Sales and Marketing AstraZeneca, Viela, biotech, drugs, pharma, pharmaceutical
Biotechs created from big pharma companies tend to have an easier start to life than most, and this is definitely …
Pharmafocus March 2018 is available to read online now!
February 28, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, brexit, drug safety, pharma, real world data
Though never truly out of vogue, the drug pricing debate has flared up again with the White House’s release of …
Generation Bio backed with $100m financing round
February 28, 2018Research and Development, Sales and Marketing Generation Bio, biotech, drugs, pharma, pharmaceutical
At the start of year, Generation Bio was revealed to the public, announcing that it had been developing gene therapies …
UK Government announces prescription price hike to record level
February 27, 2018Manufacturing and Production, Medical Communications, Sales and Marketing NHS, pharma, prescription, price
The UK Government has announced plans to increase prescription charges by 20p, or 2.3%, to a record £8.80, effective 1 …
Allergan’s patent gamble fails
February 27, 2018Manufacturing and Production, Medical Communications Allergan, Mylan, biotech, drugs, patent, pharma, pharmaceutical
Allergan’s patent deal with the Saint Regis Mohawk Tribe, in an attempt to protect itself from an inter partes review …
FDA to fight opioid crisis with wider access to medication-assisted treatment
February 27, 2018Manufacturing and Production, Medical Communications, Research and Development Alex Azar, FDA, medication-assisted treatment, opioid crisis, opioids, pharma
The FDA is set to refocus its efforts in combating the United States’ opioid crisis. Speaking at a meeting of …
UK govt report looks to reduce vaccination spending
February 27, 2018Manufacturing and Production, Medical Communications Vaccine, biotech, drugs, meningitis, pharma, pharmaceutical
One of the largest petitions ever to have gone before UK parliament, after it attracted 823,349 signatures, brought about the …
FDA expands indication of Lilly’s Verzenio in advanced breast cancer
February 27, 2018Manufacturing and Production, Sales and Marketing Cancer, Eli Lilly, FDA, Verzenio, breast cancer, pharma
Eli Lilly is celebrating the news that its cyclin-dependent kinase (CDK) 4 & 6 inhibitor Verzenio (ademaciclib) has received approval …
UK to crack down on 237m annual medication errors
February 23, 2018Medical Communications Jeremy Hunt, NHS, biotech, drugs, pharma, pharmaceutical
A new study commissioned by the Department of Health and Social Care has revealed that 237 million medication errors are …
Top Ten most popular articles on Pharmafile.com this week
February 23, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Alzheimer's, AstraZeneca, Eylea, FDA, Microsoft, Regeneron, Shire, Tremfya, eurordis, multiple myeloma, rare disease
It’s the last Friday of February, and it’s time for another run-down of the most popular stories of the week. …
Lab-grown tumours able to predict drug efficacy
February 23, 2018Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical
One of the key challenges facing the treatment of cancer is knowing whether a particular drug will work with an …
Novo Nordisk delivers in much-anticipated oral semaglutide diabetes trial
February 23, 2018Medical Communications, Research and Development Novo Nordisk, diabetes, pharma, semaglutide, type 2 diabetes
Novo Nordisk has lifted the curtain on much-anticipated results data from the first of ten Phase 3 trials into the …
Gilead seals $3bn deal, hoping for off-the-shelf CAR-T
February 23, 2018Medical Communications, Sales and Marketing CAR-T, Gilead, Kite, Sangamo Therapeutics, biotech, drugs, pharma, pharmaceutical
The expense and laborious process involved in bringing CAR-T therapies to patients was used a key reason for the high …
Insider Interview: Allergan’s R&D Chief on plans to be “the headache company”
February 22, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, David Nicholson, Insider Interview, migraine, pharma
Speaking to Pharmafocus , David Nicholson, Chief R&D Officer at Allergan, revealed that the company has big plans in the …
AllTrials puts FDA under pressure with Trials Tracker
February 22, 2018Medical Communications alltrials, biotech, drugs, pharma, pharmaceutical
A year to the day that the FDA unveiled its Final Rule, which sees organisation given 13 months from clinical …
NICE rejects Eisai’s Halaven in earlier setting for metastatic breast cancer
February 22, 2018Sales and Marketing Brest cancer, Cancer, Eisai, Halaven, NICE, pharma
NICE has published its decision not to recommend Eisai’s Halaven (eribulin) in the treatment of locally advanced or metastatic breast …
CDC U-turns previous decision on AZ’s flu vaccine
February 22, 2018Sales and Marketing AstraZeneca, Vaccine, biotech, drugs, flu, influenza, pharma, pharmaceutical
The US Centers for Disease Control and Prevention (CDC) has now recommended AstraZeneca’s FluMist as an option for doctors for …
Reports increasing of worrying side-effects with Regeneron’s Eylea
February 22, 2018Medical Communications, Research and Development, Sales and Marketing Eylea, FDA, Regeneron, pharma
Reports are emerging which detail some pretty alarming side-effects in patients receiving Regeneron’s blockbuster eye drug Eylea: once injected into …
Greek parliament moves to investigate 10 politicians
February 22, 2018Medical Communications, Sales and Marketing Greece, Greek Parliament, Novartis, biotech, drugs, pharma, pharmaceutical
After a 20-hour debate, Greek parliament has voted in favour of investigating 10 politicians named as part of an investigation …
MSD poised to acquire viral immuno-oncology firm Viralytics for $394m
February 21, 2018Research and Development, Sales and Marketing Cancer, MSD, Merck, Viralytics, acquisition, keytruda, oncology, pharma
MSD, known as Merck in the US, has announced it is to buy Australian viral immuno-oncology firm Viralytics for $394 …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
